Corcept Therapeutics Incorporated
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership1,553,135 shares
Latest Disclosed Value $ 62,596,749
Dimensional Fund Advisors Lp reports 4.15% decrease in ownership of CORT / Corcept Therapeutics Incorporated

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 1,553,135 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $62,606,872 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,620,333 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -4.15% during the quarter. The current value of the position is $112,788,664 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,553,135 -67,198 -4.15 62,597 10.64 0.0130
2026-02-12 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,620,333 -272,115 -14.38 56,577 -64.03 0.0119
2025-11-12 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,892,448 -193,069 -9.26 157,285 2.75 0.0338
2025-08-12 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 2,085,517 -50,993 -2.39 153,078 -37.19 0.0354
2025-05-13 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,136,510 57,942 2.79 243,708 132.67 0.0606
2025-02-13 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 2,078,568 -453,931 -17.92 104,742 -10.62 0.0252
2024-11-07 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 2,532,499 -143,836 -5.37 117,191 34.78 0.0284
2024-08-09 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 2,676,335 108,658 4.23 86,952 34.44 0.0227
2024-05-10 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,567,677 257,380 11.14 64,680 -13.81 0.0175
2024-02-07 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 2,310,297 2,953 0.13 75,041 19.31 0.0219
2023-11-09 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 2,307,344 52,878 2.35 62,895 25.39 0.0206
2023-08-09 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 2,254,466 100,459 4.66 50,159 7.51 0.0160
2023-05-12 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,154,007 68,382 3.28 46,656 110,983.33 0.0157
2023-02-09 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 2,085,625 -18,858 -0.90 42 -99.92 0.0125
2022-11-10 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 2,104,483 16,811 0.81 53,959 8.68 0.0207
2022-08-12 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 2,087,672 146,846 7.57 49,648 13.57 0.0178
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,940,826 57,360 3.05 43,716 17.23 0.0135
2022-02-09 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,883,466 -716,179 -27.55 37,291 -27.11 0.0113
2021-11-12 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 2,599,645 -192,534 -6.90 51,163 -16.71 0.0165
2021-08-12 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 2,792,179 179,695 6.88 61,429 -1.08 0.0194
2021-05-14 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,612,484 44,432 1.73 62,097 -7.57 0.0205
2021-03-08 2020-12-31 13F/A-2 CORCEPT THERAPEUTICS COM 218352102 2,568,052 -31,191 -1.20 67,180 48.50 0.0243
2021-02-11 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 2,568,052 -31,191 67,180 24,261.8452
2020-11-12 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 2,599,243 -22,126 -0.84 45,240 2.61 0.0192
2020-08-13 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 2,621,369 50,759 1.97 44,091 44.26 0.0194
2020-05-14 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,570,610 40,593 1.60 30,563 -0.16 0.0159
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 2,530,017 -18,670 -0.73 30,613 -15.03 0.0112
2019-11-12 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 2,548,687 38,775 1.54 36,027 28.73 0.0140
2019-08-13 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 2,509,912 203,177 8.81 27,986 3.35 0.0109
2019-08-12 2019-03-31 13F/A-2 CORCEPT THERAPEUTICS COM 218352102 2,306,735 403,699 21.21 27,080 6.51 0.0108
2019-05-10 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,306,735 403,699 27,080
2019-02-26 2018-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 1,903,036 120,758 6.78 25,424 1.75 0.0115
2019-02-13 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,903,036 120,758 25,424
2018-11-13 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,782,278 128,416 7.76 24,987 -3.89 0.0095
2018-08-10 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,653,862 77,213 4.90 25,999 0.24 0.0104
2018-05-11 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,576,649 306,691 24.15 25,936 13.08 0.0108
2018-02-12 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,269,958 65,633 5.45 22,936 -1.32 0.0095
2017-11-13 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,204,325 355,006 41.80 23,242 131.91 0.0102
2017-08-11 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 849,319 386,431 83.48 10,022 97.52 0.0046
2017-05-12 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 462,888 358,885 345.07 5,074 572.05 0.0024
2017-02-09 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 104,003 104,003 0.00 755 0.0004
2016-08-09 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -10,071 -100.00 0 -100.00
2016-05-13 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 10,071 -89,221 -89.86 47 -90.49 0.0000
2016-02-10 2015-12-31 13F CORCEPT THERAPEUTICS COM 218352102 99,292 -206,608 -67.54 494 -57.04 0.0003
2015-11-13 2015-09-30 13F CORCEPT THERAPEUTICS COM 218352102 305,900 -62,779 -17.03 1,150 -48.10 0.0008
2015-08-14 2015-06-30 13F CORCEPT THERAPEUTICS COM 218352102 368,679 0 0.00 2,216 7.31 0.0014
2015-05-14 2015-03-31 13F CORCEPT THERAPEUTICS COM 218352102 368,679 -14,228 -3.72 2,065 79.72 0.0013
2015-02-06 2014-12-31 13F CORCEPT THERAPEUTICS COM 218352102 382,907 0 0.00 1,149 11.99 0.0008
2014-11-13 2014-09-30 13F CORCEPT THERAPEUTICS COM 218352102 382,907 0 0.00 1,026 -4.29 0.0007
2014-08-08 2014-06-30 13F CORCEPT THERAPEUTICS COM 218352102 382,907 -4,500 -1.16 1,072 -36.53 0.0007
2014-05-14 2014-03-31 13F CORCEPT THERAPEUTICS COM 218352102 387,407 0 0.00 1,689 35.45 0.0013
2014-02-12 2013-12-31 13F CORCEPT THERAPEUTICS COM 218352102 387,407 -4,200 -1.07 1,247 100.16 0.0010
2013-11-13 2013-09-30 13F CORCEPT THERAPEUTICS COM 218352102 391,607 0 0.00 623 -7.98 0.0005
2013-08-15 2013-06-30 13F CORCEPT THERAPEUTICS COM 218352102 391,607 391,607 677 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.